Oxurion NV
Acquires European pharmaceutical subcontractors to build an integrated healthcare services group.
OXUR | BR
Overview
Corporate Details
- ISIN(s):
- BE0974487192
- LEI:
- 549300VWY8KVDFKLDM59
- Country:
- Belgium
- Address:
- Gaston Geenslaan 1, 3001 Heverlee
- Website:
- https://oxurion.com/
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
Oxurion is a company specializing in acquiring majority stakes in promising European pharmaceutical subcontractors. Its ambition is to build an integrated group of subcontractors to serve healthcare stakeholders. The company holds a 72% stake in Axiodis CRO, a contract research organization specialized in biometrics. This strategy represents a shift from its historical focus as a biopharmaceutical company developing therapies for retinal diseases like Geographic Atrophy (GA) and Age-related Macular Degeneration (AMD).
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-10-02 18:00 |
Major Shareholding Notification
OXUR-Transparency-Notification-EN-20251002.pdf
|
English | 352.2 KB | ||
| 2025-10-02 18:00 |
Major Shareholding Notification
OXUR-Transparency-Notification-NL-20251002.pdf
|
Dutch | 378.2 KB | ||
| 2025-09-30 18:00 |
Interim Report
OXUR GLOBAL - Financial report 30-06-2025 (EN) FINAL.pdf
|
English | 412.9 KB | ||
| 2025-09-30 18:00 |
Interim Report
OXUR GLOBAL - Financial report 30-06-2025 (NL) FINAL.pdf
|
Dutch | 420.8 KB | ||
| 2025-09-30 18:00 |
Report Publication Announcement
OXUR_Publish-H1-2025-results_EN.pdf
|
English | 211.4 KB | ||
| 2025-09-30 18:00 |
Report Publication Announcement
OXUR_Publication-H1-2025-resultats_FR.pdf
|
French | 161.8 KB | ||
| 2025-09-30 18:00 |
Report Publication Announcement
OXUR_Publicatie-H1-2025-resultaten_NL.pdf
|
Dutch | 211.0 KB | ||
| 2025-09-08 18:00 |
Major Shareholding Notification
OXUR-Transparency-Notification-EN-20250903.pdf
|
English | 371.9 KB | ||
| 2025-09-08 18:00 |
Major Shareholding Notification
OXUR-Transparency-Notification-NL-20250903.pdf
|
Dutch | 396.3 KB | ||
| 2025-09-01 18:00 |
Capital/Financing Update
OXUR-Contrat-atlas-crypto-EN-20250901.pdf
|
English | 190.2 KB | ||
| 2025-09-01 18:00 |
Capital/Financing Update
OXUR-Contrat-atlas-crypto-FR-20250901.pdf
|
French | 125.2 KB | ||
| 2025-09-01 18:00 |
Capital/Financing Update
OXUR-Contrat-atlas-crypto-NL-20250901-1.pdf
|
Dutch | 214.2 KB | ||
| 2025-09-01 18:00 |
Major Shareholding Notification
OXUR-Transparency-Notification-EN-20250901.pdf
|
English | 1.2 MB | ||
| 2025-09-01 18:00 |
Major Shareholding Notification
OXUR-Transparency-Notification-NL-20250901.pdf
|
English | 1.3 MB | ||
| 2025-08-07 18:00 |
Legal Proceedings Report
OXUR-New-Development-Strategy-EN-20250806.pdf
|
English | 195.7 KB |
Automate Your Workflow. Get a real-time feed of all Oxurion NV filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Oxurion NV via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2022-03-07 | Bareldam SA | Close relation | Buy | 1,180,555 | 1,700,000.00 EUR |
| 2021-09-30 | Lavinia D. Clay 2009 Revocable Trust | Close relation | Other | 2,766,337 | 5,601,002.52 EUR |
%20Co.%2C%20Ltd/other/SLSBioSpecialty_Lab_Solution_Bio_Co._Ltd-logo.jpg){kind=logo}
